Abstract
Chemical analogues which enhance one or several biologic properties of important naturally occurring substances are regularly sought. Currently in this regard, there is intense interest in developing such analogues of the neurohypophyseal hormones (NHPH), oxytocin and vasopressin. Several which have recently been synthesized not only offer the possibility of increased insight into structure-activity relationships but also may provide for more precise therapeutic drug actions (17).
This study was supported by research grants HE-12462 and HE-11391 from the National Institutes of Health, USPHS, Bethesda, Maryland.
Recipient of Research Career Development Award 5-K3-GM-38, 603 from the N.I.H., USPHS.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
B.M. Altura, “Differential actions of polypeptides and other drugs on coronary inflow vessels,” Am. Heart J., 72: 709–711, 1966.
B.M. Altura, “Evaluation of neurohumoral substances in local regulation of blood flow,” Am. J. Physiol., 212: 1447–1454, 1967.
B.M. Altura, “Significance of amino acid residues in vasopressin on contraction in vascular muscle,” Am. J. Physiol., 219: 222–229, 1970.
B.M. Altura, “Influence of magnesium and cysteine on vasopressininduced contractions in various canine blood vessels,” Experientia, 26: 1089–1090, 1970.
B.M. Altura, “Pharmacology of neurohypophyseal hormones and analogs on isolated vascular muscle and in the terminal vascular bed,” in: J.A. Bevan, R.F. Furchgott, R.A. Maxwell and A.P. Som I yo, Eds., Physiology and Pharmacology of Vascular Neuroeffector Systems. Basel, Karger, pp. 274–290, 1971.
B.M. Altura, “Chemical and humoral regulation of blood flow through the precapillary sphincter,” Microvascular Res., 3: October, 1971 (in press).
B.M. Altura, “Structure-activity relationships of neurohypophyseal polypeptides on different types of isolated mammalian blood vessels,” in: These Proceedings.
B.M. Altura and S.G. Hershey, “Pharmacology of neurohypophyseal hormones and their synthetic analogues in the terminal vascular bed. Structure-activity relationships,” Angiology, 18: 428–439, 1967.
B.M. Altura and S.G. Hershey, “Use of reticuloendothelial phagocytic function as an index in shock therapy,” Bull. N.Y. Acad. Med., 43: 259–266, 1967.
B.M. Altura and S.G. Hershey, “Structure-activity relationships of neurohypophyseal polypeptides in the microcirculation: A molecular basis for shock therapy,” in: B. Schildt and L. Thorén, Eds., Intermedes Proceedings 1968: Combined Injuries and Shock. Stockholm, Almqvist and Wiksell, pp. 247–259, 1968.
B.M. Altura and S.G. Hershey, “Influence of vasopressor drugs on reticuloendothelial phagocytic function in experimental shock,” in: B. Schildt and L. Thorén, Eds., Intermedes Proceedings 1968: Combined Injuries and Shock. Stockholm, Almqvist and Wiksell, p. 185–193, 1968.
B.M. Altura and S.G. Hershey, “Structure-action relationships of vasopressin analogs in the microcirculation and their use in the treatment of experimental shock,” Federation Proc., 29: 711, 1970.
B.M. Altura, S.G. Hershey and B.T. Altura, “Microcirculatory actions of polypeptides and their use in the treatment of experimental shock,” Adv. Exptl. Med. Biol., 8: 239–247, 1970.
B.M. Altura, S.G. Hershey and V.D.B. Mazzia, “Microcirculatory approach to vasopressor therapy in intestinal ischemic (SMA) shock,” Am. J. Surgery, 111: 186–192, 1966.
B.M. Altura, S.G. Hershey and B.W. Zweifach, “Effects of a synthetic analogue of vasopressin on vascular smooth muscle,” Proc. Soc. Exptl. Biol. Med., 119: 258–261, 1965.
B.M. Altura, R. Hsu, V.D.B. Mazzia and S.G. Hershey, “Influence of vasopressors on survival after traumatic, intestinal ischemia and endotoxin shock in rats,” Proc. Soc. Exptl. Biol. Med., 119: 389393, 1965.
B. Berde, Ed., “Handbook of Experimental Pharmacology, vol. 23: Neurohypophysial Hormones and Similar Polypeptides.” Berlin, Springer-Verlag, 1968.
B. Berde and R.A. Boissonnas, “Basic pharmacological properties of synthetic analogues and homologues of the neurohypophysial hormones,” in: B. Berde, Ed., Handbook of Experimental Pharmacology, vol. 23: Neurohypophysial Hormones and Similar Polypeptides. Berlin, Springer-Verlag, pp. 802–870, 1968.
B. Berde, R.A. Boissonnas, R. Huguenin and E. StUrmer, “Vasopressin analogues with selective pressor activity,” Experientia, 20: 42–44, 1964.
P. Brazeau, “Agents affecting the renal conservation of water,” in: L.S. Goodman and A. Gilman, Eds., The Pharmacological Basis of Therapeutics. New York, Macmillan, pp. 874–885, 1970.
J.N. Cohn, F.E. Tristani and I.M. Khatri, “Systemic vasoconstrictor and renal vasodilator effects of PLV-2 (Octapressin) in man,” Circulation, 38: 151–157, 1968.
S.G. Hershey and B.M. Altura, “Behandlung des Schocks durch Beeinflussung der peripheren Zirkulation mit vasoaktiven Wirkstoffen: eine mikrozirkulatorische Basis für die Therapie,” Schweiz. Med. Wschr. 96: 1467–1471, 1516–1522, 1966 (2 parts).
S.G. Hershey, B.M. Altura and L.R. Orkin, “Therapy of intestinal ischemic (SMA) shock with vasoactive drugs,” Anesthesiology, 29: 466471, 1968.
S.G. Hershey, V.D.B. Mazzia, B.M. Altura and L. Gyure, “Effects of vasopressors on the microcirculation and on survival in hemorrhagic shock,” Anesthesiology, 26: 179–189, 1965.
M.E. Hunter and R.A. Gordon, “Laboratory and clinical studies of 2phenylalanine-8-lysine vasopressin (Octapressin),” Canad. Anaesth. Soc. J., 13: 40–45, 1966.
R.L. Katz, “Epinephrine and PLV-2: Cardiac rhythm and local vasoconstrictor effects,” Anesthesiology, 26: 619–623, 1965.
R.L. Katz and G.J. Katz, “Surgical infiltration of pressor drugs and their interaction with volatile anesthetics,” Brit. J. Anaesth., 38: 712–718, 1966.
O.V. Nielsen and N. Valentin, “Ornithine-8-vasopressin, a new vasoconstrictor used for haemostasis during operation for genital prolapse,” Acta Obstet. Gynec. Scand., 49: 45–48, 1970.
K. Saameli, “The circulatory actions of the neurohypophysial hormones and similar polypeptides.” Berlin, Springer-Verlag, pp. 545–612, 1968.
H.B. Ban Dyke, K. Adamsons and S.L. Engel, “Aspects of the biochemistry and physiology of the neurohypophyseal hormones. Recent Progr. Hormone Res., 11: 1–35, 1955.
V. du Vigneaud, H.C. Lawler and E.A. Popenoe, “Enzymatic cleavage of glycinamide from vasopressin and a proposed structure for this pressor-antidiuretic hormone of the posterior pituitary,” J.Am. Chem. Soc., 75: 4880–4881, 1953.
V. du Vigneaud, C.H. Ressler, J.M. Swan, C.W. Roberts, P.G. Katsoyannis and S. Gordon, “The synthesis of an octapeptide amide with the hormonal activity of oxytocin.” J. Am. Chem. Soc., 75: 4879–4880, 1953.
B.W. Zweifach, “Functional Behavior of the Microcirculation.” Springfield, C.C. Thomas, 1961.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Plenum Press, New York
About this chapter
Cite this chapter
Altura, B.M., Hershey, S.G. (1972). A Structure-Activity Basis for Vasotropic Peptide Therapy in Shock. In: Back, N., Sicuteri, F. (eds) Vasopeptides. Advances in Experimental Medicine and Biology, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7439-8_47
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7439-8_47
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7441-1
Online ISBN: 978-1-4684-7439-8
eBook Packages: Springer Book Archive